NASDAQ:ZTEK · NASDAQ
+$0.10 today
Vol 0.04M · Avg 0.15M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Management quality matters because capital allocation choices determine how much of Zentek Ltd. earnings power becomes long-term shareholder value. Use this page to compare ZTEK returns on capital, executive context, insider transactions, ownership signals, and growth trends against peers, then decide whether leadership appears disciplined, aligned, and capable of compounding through changing market conditions.
Return Metrics
ROE, ROIC & ROA over time
ROE
-99.7%
avg -41.5%
ROIC
-92.4%
avg -34.6%
ROA
-64.7%
avg -35.1%
Analysis
ROA is currently the strongest return metric at -64.7% versus its period average of -35.1%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Mohammed Jiwan | Chief Executive Officer & Director | $232,836.00 | — | — | — | — |
Wendy Ford | Chief Financial Officer | $177,010.00 | — | — | — | — |
Ryan Shacklock | Senior Vice President of Strategy & Business Development | $122,924.00 | — | — | — | — |
Eric Wallman | Board Secretary & Director | $68,486.00 | — | — | — | — |
John Snisarenko | Secretary & Board Chair | $31,609.00 | — | 63 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | N/A1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
ALX Oncology Holdings Inc.
NASDAQ:ALXO
$274.51M
American Well Corporation
NYSE:AMWL
$153.55M
Hyperfine, Inc.
NASDAQ:HYPR
$123.80M
Cardiol Therapeutics Inc.
NASDAQ:CRDL
$119.88M
Microbot Medical Inc.
NASDAQ:MBOT
$80.66M
MindWalk Holdings Corp.
NASDAQ:HYFT
$73.80M
BeyondSpring Inc.
NASDAQ:BYSI
$69.49M
Fractyl Health, Inc.
NASDAQ:GUTS
$53.64M
Who manages ZTEK?
Zentek Ltd. (ZTEK) lists 5 active executives. The top listed executive is Mohammed Jiwan, Chief Executive Officer & Director.
Explore More
Continue the stock analysis
Jump to another research area for this company.